cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2026.4.n3228cardio-3228Research ArticleНЕКРОЛОГПамяти профессора Юджина БраунвальдаIn Memory of Professor Eugene Braunwald (August 15, 1929 – April 22, 2026)https://orcid.org/0000-0002-3014-6129БеленковЮ. Н.BelenkovYu. N.

академик РАН, доктор медицинских наук, профессор, заместитель директора по науке 

Head of the Department of Hospital Therapy No. 1, N.V. Sklifosovsky Institute of Medical Sciences, MD, Professor, Academician of the Russian Academy of Sciences

ynbelenkov@gmail.comФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова» Минздрава РФ (Сеченовский Университет), МоскваРоссияSechenov First Moscow State Medical University (Sechenov University), MoscowRussian Federation20260506202666498100Copyright © Kardiomag, 20262026KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/3228

Памяти профессора Юджина Браунвальда

In Memory of Professor Eugene Braunwald

(August 15, 1929 – April 22, 2026)

Памяти профессора Юджина Браунвальдакардиологияишемическая болезнь сердцасердечная недостаточностьIn Memory of Professor Eugene Braunwald (August 151929 – April 222026)Финансирование Финансирование отсутствует (из собственных ресурсов). Конфликт интересов не заявляется.Funding None. The authors declare no conflict of interest.ReferencesLibby P, Pfeffer MA. Happy birthday, Dr Braunwald! European Heart Journal. 2025;46(2):110–2. DOI: 10.1093/eurheartj/ehae725Libby P, Pfeffer MA. Happy birthday, Dr Braunwald! European Heart Journal. 2025;46(2):110–2. DOI: 10.1093/eurheartj/ehae725Braunwald E. Control of myocardial oxygen consumption. The American Journal of Cardiology. 1971;27(4):416–32. DOI: 10.1016/0002-9149(71)90439-5Braunwald E. Control of myocardial oxygen consumption. The American Journal of Cardiology. 1971;27(4):416–32. DOI: 10.1016/0002-9149(71)90439-5Braunwald E. Unstable angina. A classification. Circulation. 1989;80(2):410–4. DOI: 10.1161/01.CIR.80.2.410Braunwald E. Unstable angina. A classification. Circulation. 1989;80(2):410–4. DOI: 10.1161/01.CIR.80.2.410Braunwald E. Unstable Angina: An Etiologic Approach to Management. Circulation. 1998;98(21):2219–22. DOI: 10.1161/01.CIR.98.21.2219Braunwald E. Unstable Angina: An Etiologic Approach to Management. Circulation. 1998;98(21):2219–22. DOI: 10.1161/01.CIR.98.21.2219Antman EM, Braunwald E. Acute Coronary Syndromes: a holistic view. JACC. 2025;85(22):2057–60. DOI: 10.1016/j.jacc.2025.03.538Antman EM, Braunwald E. Acute Coronary Syndromes: a holistic view. JACC. 2025;85(22):2057–60. DOI: 10.1016/j.jacc.2025.03.538The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings. New England Journal of Medicine. 1985;312(14):932–6. DOI: 10.1056/NEJM198504043121437The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings. New England Journal of Medicine. 1985;312(14):932–6. DOI: 10.1056/NEJM198504043121437Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure. New England Journal of Medicine. 1991;325(5):293–302. DOI: 10.1056/NEJM199108013250501Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure. New England Journal of Medicine. 1991;325(5):293–302. DOI: 10.1056/NEJM199108013250501Morrow DA, Velazquez EJ, Desai AS, DeVore AD, Lepage S, Park J-G et al. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. Journal of the American College of Cardiology. 2024;83(12):1123–32. DOI: 10.1016/j.jacc.2024.01.027Morrow DA, Velazquez EJ, Desai AS, DeVore AD, Lepage S, Park J-G et al. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. Journal of the American College of Cardiology. 2024;83(12):1123–32. DOI: 10.1016/j.jacc.2024.01.027Mann DL, Nicolas J, Claggett B, Miao ZM, Granger CB, Kerkar P et al. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI. Journal of the American College of Cardiology. 2024;83(9):904–14. DOI: 10.1016/j.jacc.2024.01.002Mann DL, Nicolas J, Claggett B, Miao ZM, Granger CB, Kerkar P et al. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI. Journal of the American College of Cardiology. 2024;83(9):904–14. DOI: 10.1016/j.jacc.2024.01.002The GUSTO Investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction. New England Journal of Medicine. 1993;329(10):673–82. DOI: 10.1056/NEJM199309023291001The GUSTO Investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction. New England Journal of Medicine. 1993;329(10):673–82. DOI: 10.1056/NEJM199309023291001Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis in Myocardial Infarction 22. (PROVE-IT TIMI 22). New England Journal of Medicine. 2004;350(15):1495–504. DOI: 10.1056/NEJMoa040583Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis in Myocardial Infarction 22. (PROVE-IT TIMI 22). New England Journal of Medicine. 2004;350(15):1495–504. DOI: 10.1056/NEJMoa040583Libby P. Atherosclerosis: The New View. Scientific American. 2002;286(5):46–55. DOI: 10.1038/scientificamerican0502-46Libby P. Atherosclerosis: The New View. Scientific American. 2002;286(5):46–55. DOI: 10.1038/scientificamerican0502-46Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement. JACC. 2026;87(11):1381–404. DOI: 10.1016/j.jacc.2025.08.047Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement. JACC. 2026;87(11):1381–404. DOI: 10.1016/j.jacc.2025.08.047Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 2017;377(12):1119–31. DOI: 10.1056/NEJMoa1707914Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 2017;377(12):1119–31. DOI: 10.1056/NEJMoa1707914Braunwald E. Aortic Stenosis: a 6-decade odyssey. Journal of the American College of Cardiology. 2023;82(22):2110–2. DOI: 10.1016/j.jacc.2023.10.001Braunwald E. Aortic Stenosis: a 6-decade odyssey. Journal of the American College of Cardiology. 2023;82(22):2110–2. DOI: 10.1016/j.jacc.2023.10.001Lindman BR, Braunwald E, Pellikka PA. Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis – The Time Has Come. JAMA Cardiology. 2025;10(4):305–6. DOI: 10.1001/jamacardio.2024.5648Lindman BR, Braunwald E, Pellikka PA. Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis – The Time Has Come. JAMA Cardiology. 2025;10(4):305–6. DOI: 10.1001/jamacardio.2024.5648Braunwald E, Bristow MR. Congestive Heart Failure: Fifty Years of Progress. Circulation. 2000;102(Suppl 4):IV-14-IV–23. DOI: 10.1161/01.CIR.102.suppl_4.IV-14Braunwald E, Bristow MR. Congestive Heart Failure: Fifty Years of Progress. Circulation. 2000;102(Suppl 4):IV-14-IV–23. DOI: 10.1161/01.CIR.102.suppl_4.IV-14Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161–72. DOI: 10.1161/01. cir.81.4.1161Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161–72. DOI: 10.1161/01. cir.81.4.1161Regan JA, Laitner MH, Dzau VJ. Cardiovascular Science, Medicine, and Society: The Brave New World: the ACC Braunwald Lecture 2025. JACC. 2026;87(15):1973–85. DOI: 10.1016/j.jacc.2025.12.085Regan JA, Laitner MH, Dzau VJ. Cardiovascular Science, Medicine, and Society: The Brave New World: the ACC Braunwald Lecture 2025. JACC. 2026;87(15):1973–85. DOI: 10.1016/j.jacc.2025.12.085Braunwald E, Saberi S, Abraham TP, Elliott PM, Olivotto I. Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy. European Heart Journal. 2023;44(44):4622–33. DOI: 10.1093/eurheartj/ehad637Braunwald E, Saberi S, Abraham TP, Elliott PM, Olivotto I. Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy. European Heart Journal. 2023;44(44):4622–33. DOI: 10.1093/eurheartj/ehad637Braunwald’s heart disease: a textbook of cardiovascular medicine. Libby P, Braunwald E, editors - Philadelphia: Saunders/Elsevier; 2008. - 2136p. ISBN 978-1-4160-4106-1Braunwald’s heart disease: a textbook of cardiovascular medicine. Libby P, Braunwald E, editors - Philadelphia: Saunders/Elsevier; 2008. - 2136p. ISBN 978-1-4160-4106-1Braunwald’s heart disease: a textbook of cardiovascular medicine. Libby P, Bonow R, Mann D, Tomaselli G, Bhatt D, Solomon S, editors – Philadelphia: Elsevier; 2021. – 2032p. ISBN 978-0-323-72219-3Braunwald’s heart disease: a textbook of cardiovascular medicine. Libby P, Bonow R, Mann D, Tomaselli G, Bhatt D, Solomon S, editors – Philadelphia: Elsevier; 2021. – 2032p. ISBN 978-0-323-72219-3Braunwald E. Cardiology: A Century of Progress. Circulation. 2024;149(2):78–9. DOI: 10.1161/CIRCULATIONAHA.123.064458Braunwald E. Cardiology: A Century of Progress. Circulation. 2024;149(2):78–9. DOI: 10.1161/CIRCULATIONAHA.123.064458Bhatt DL, Goldman ME. The Legends Colloquium: a conversation between Eugene Braunwald and Valentin Fuster. Journal of the American College of Cardiology. 2024;83(9):951–5. DOI: 10.1016/j.jacc.2024.01.019Bhatt DL, Goldman ME. The Legends Colloquium: a conversation between Eugene Braunwald and Valentin Fuster. Journal of the American College of Cardiology. 2024;83(9):951–5. DOI: 10.1016/j.jacc.2024.01.019

The authors declare that there are no conflicts of interest present.